| Literature DB >> 26850306 |
Vincent Andermark1, Katrin Göke2, Malte Kokoschka3, Mohamed A Abu El Maaty4, Ching Tung Lum5, Taotao Zou5, Raymond Wai-Yin Sun5, Elisabet Aguiló6, Luciano Oehninger1, Laura Rodríguez6, Heike Bunjes2, Stefan Wölfl4, Chi-Ming Che5, Ingo Ott7.
Abstract
Gold alkynyl complexes with phosphane ligands of the type (alkynyl)Au(I)(phosphane) represent a group of bioorganometallics, which has only recently been evaluated biologically in more detail. Structure-activity-relationship studies regarding the residues of the phosphane ligand (P(Ph)3, P(2-furyl)3, P(DAPTA)3, P(PTA)3, P(Et)3, P(Me)3) of complexes with an 4-ethynylanisole alkyne ligand revealed no strong differences concerning cytotoxicity. However, a relevant preference for the heteroatom free alkyl/aryl residues concerning inhibition of the target enzyme thioredoxin reductase was evident. Complex 1 with the triphenylphosphane ligand was selected for further studies, in which clear effects on cell morphology were monitored by time-lapse microscopy. Effects on cellular signaling were determined by ELISA microarrays and showed a significant induction of the phosphorylation of ERK1 (extracellular signal related kinase 1), ERK2 and HSP27 (heat shock protein 27) in HT-29 cells. Application of 1 in-vivo in a mouse xenograft model was found to be challenging due to the low solubility of the complex and required a formulation strategy based on a peanut oil nanoemulsion.Entities:
Keywords: Alkyne; Cancer; Formulation; Gold; Microarray; Xenograft
Mesh:
Substances:
Year: 2015 PMID: 26850306 DOI: 10.1016/j.jinorgbio.2015.12.020
Source DB: PubMed Journal: J Inorg Biochem ISSN: 0162-0134 Impact factor: 4.155